BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

13101

524394

VIMTALABS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

VIMTA LABS LIMITED performance

Today’s low

Today’s high

₹ 991.30 ₹ 1046.30
₹ 998.90

52 week low

52 week high

₹ 420.00 ₹ 1178.00
₹ 998.90

Open Price

₹ 1045.90

Prev. Close

₹ 1037.60

Volume (Shares)

173423.00

Total traded value

₹ 1732.32

Upper Circuit

₹ 1245.10

Lower Circuit

₹ 830.10

info

VIMTA LABS LIMITED Share Price Update

As of the latest trading session, VIMTA LABS LIMITED share price is currently at ₹ 998.9, which is down by ₹ -38.69 from its previous closing. Today, the stock has fluctuated between ₹ 991.30 and ₹ 1046.30. Over the past year, VIMTA LABS LIMITED has achieved a return of 86.44 %. In the last month alone, the return has been 3.48 %. Read More...

VIMTA LABS LIMITED fundamentals


  • Market cap (Cr)

    2,214.62

  • P/E Ratio (TTM)

    33.03

  • Beta

    1.16

  • Book Value / share

    170.38

  • Return on equity

    13.00%

  • EPS (TTM)

    30.02

  • Dividend yield

    0.20%

  • Net profit/quarter (Cr)

    18.32

info icon alternate text
  • Market cap (Cr)

    2,220.93

  • P/E Ratio (TTM)

    33.03

  • Beta

    1.09

  • Book Value / share

    170.38

  • Return on equity

    13.00%

  • EPS (TTM)

    30.02

  • Dividend yield

    0.20%

  • Net profit/quarter (Cr)

    18.32

info icon alternate text

VIMTA LABS LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 94.44
Operating Expense 71.06
Net Profit 18.32
Net Profit Margin (%) 19.39
Earnings Per Share (EPS) 8.22
EBITDA 34.68
Effective Tax Rate (%) 26.80
Particulars DEC 2024 (Values in Cr)
Revenue 89.92
Operating Expense 67.23
Net Profit 21.50
Net Profit Margin (%) 23.91
Earnings Per Share (EPS) 9.65
EBITDA 34.31
Effective Tax Rate (%) 26.75
Particulars SEP 2024 (Values in Cr)
Revenue 83.14
Operating Expense 62.83
Net Profit 14.59
Net Profit Margin (%) 17.54
Earnings Per Share (EPS) 6.58
EBITDA 29.63
Effective Tax Rate (%) 22.09
Particulars JUN 2024 (Values in Cr)
Revenue 73.32
Operating Expense 56.69
Net Profit 11.64
Net Profit Margin (%) 15.87
Earnings Per Share (EPS) 5.25
EBITDA 25.69
Effective Tax Rate (%) 23.39
Particulars MAR 2024 (Values in Cr)
Revenue 72.73
Operating Expense 55.19
Net Profit 12.35
Net Profit Margin (%) 16.98
Earnings Per Share (EPS) 5.58
EBITDA 26.31
Effective Tax Rate (%) 22.18
Particulars MAR 2025 (Values in Cr)
Revenue 343.98
Operating Expense 259.21
Net Profit 67.34
Net Profit Margin (%) 19.57
Earnings Per Share (EPS) 30.28
EBITDA 126.19
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 288.60
Operating Expense 229.79
Net Profit 41.01
Net Profit Margin (%) 14.20
Earnings Per Share (EPS) 18.52
EBITDA 97.74
Effective Tax Rate (%) 21.90
Particulars MAR 2023 (Values in Cr)
Revenue 315.12
Operating Expense 254.75
Net Profit 47.30
Net Profit Margin (%) 15.01
Earnings Per Share (EPS) 21.37
EBITDA 97.00
Effective Tax Rate (%) 25.89
Particulars MAR 2022 (Values in Cr)
Revenue 275.98
Operating Expense 220.87
Net Profit 41.06
Net Profit Margin (%) 14.87
Earnings Per Share (EPS) 18.57
EBITDA 80.01
Effective Tax Rate (%) 25.81
Particulars MAR 2021 (Values in Cr)
Revenue 209.05
Operating Expense 181.47
Net Profit 21.26
Net Profit Margin (%) 10.16
Earnings Per Share (EPS) 9.62
EBITDA 53.51
Effective Tax Rate (%) 25.14
Particulars MAR 2024 (Values in Cr)
Book Value / Share 144.20
ROE % 13.64
ROCE % 16.99
Total Debt to Total Equity 0.06
EBITDA Margin 28.53
Particulars MAR 2023 (Values in Cr)
Book Value / Share 127.33
ROE % 18.68
ROCE % 23.48
Total Debt to Total Equity 0.07
EBITDA Margin 30.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 105.83
ROE % 19.30
ROCE % 22.76
Total Debt to Total Equity 0.12
EBITDA Margin 28.93
Particulars MAR 2021 (Values in Cr)
Book Value / Share 87.92
ROE % 11.66
ROCE % 13.58
Total Debt to Total Equity 0.17
EBITDA Margin 25.53
Particulars MAR 2020 (Values in Cr)
Book Value / Share 78.19
ROE % 3.96
ROCE % 5.58
Total Debt to Total Equity 0.19
EBITDA Margin 18.24
Particulars MAR 2024 (Values in Cr)
Book Value / Share 142.67
ROE % 13.00
ROCE % 16.22
Total Debt to Total Equity 0.06
EBITDA Margin 28.01
Particulars MAR 2023 (Values in Cr)
Book Value / Share 126.79
ROE % 18.40
ROCE % 23.15
Total Debt to Total Equity 0.07
EBITDA Margin 30.79
Particulars MAR 2022 (Values in Cr)
Book Value / Share 105.68
ROE % 19.19
ROCE % 22.69
Total Debt to Total Equity 0.11
EBITDA Margin 28.99
Particulars MAR 2021 (Values in Cr)
Book Value / Share 87.89
ROE % 11.58
ROCE % 13.56
Total Debt to Total Equity 0.17
EBITDA Margin 25.59
Particulars MAR 2020 (Values in Cr)
Book Value / Share 78.23
ROE % 4.02
ROCE % 5.74
Total Debt to Total Equity 0.17
EBITDA Margin 18.29
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 25.78
Total Assets 400.05
Total Liabilities 400.05
Total Equity 319.69
Share Outstanding 22170583
Price to Book Ratio 3.12
Return on Assets (%) 10.25
Return on Capital (%) 12.1
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 39.77
Total Assets 362.32
Total Liabilities 362.32
Total Equity 281.78
Share Outstanding 22128989
Price to Book Ratio 2.48
Return on Assets (%) 13.29
Return on Capital (%) 16.23
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 11.41
Total Assets 307.19
Total Liabilities 307.19
Total Equity 233.98
Share Outstanding 22107810
Price to Book Ratio 2.98
Return on Assets (%) 13.45
Return on Capital (%) 16.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.79
Total Assets 274.35
Total Liabilities 274.35
Total Equity 194.38
Share Outstanding 22107810
Price to Book Ratio 1.83
Return on Assets (%) 7.80
Return on Capital (%) 9.52
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 6.67
Total Assets 245.76
Total Liabilities 245.76
Total Equity 172.87
Share Outstanding 22107810
Price to Book Ratio 0.76
Return on Assets (%) 2.78
Return on Capital (%) 3.49
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 24.43
Total Assets 396.00
Total Liabilities 396.00
Total Equity 316.29
Share Outstanding 22170583
Price to Book Ratio 3.12
Return on Assets (%) 9.79
Return on Capital (%) 11.57
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 38.82
Total Assets 360.47
Total Liabilities 360.47
Total Equity 280.58
Share Outstanding 22128989
Price to Book Ratio 2.48
Return on Assets (%) 13.12
Return on Capital (%) 16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 11.27
Total Assets 306.23
Total Liabilities 306.23
Total Equity 233.64
Share Outstanding 22107810
Price to Book Ratio 2.98
Return on Assets (%) 13.40
Return on Capital (%) 16.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.61
Total Assets 273.07
Total Liabilities 273.07
Total Equity 194.31
Share Outstanding 22107810
Price to Book Ratio 1.83
Return on Assets (%) 7.78
Return on Capital (%) 9.49
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 6.65
Total Assets 244.53
Total Liabilities 244.53
Total Equity 172.95
Share Outstanding 22107810
Price to Book Ratio 0.76
Return on Assets (%) 2.83
Return on Capital (%) 3.55
Particulars MAR 2024 (Values in Cr)
Net Income 54.48
Cash from Operations 76.36
Cash from Investing -76.04
Cash from Financing -1.90
Net change in Cash -17.05
Free Cash Flow 152.69
Particulars MAR 2023 (Values in Cr)
Net Income 64.99
Cash from Operations 100.46
Cash from Investing -57.25
Cash from Financing -10.98
Net change in Cash 19.70
Free Cash Flow 148.28
Particulars MAR 2022 (Values in Cr)
Net Income 55.68
Cash from Operations 75.70
Cash from Investing -37.84
Cash from Financing -16.61
Net change in Cash 4.60
Free Cash Flow 105.49
Particulars MAR 2021 (Values in Cr)
Net Income 28.54
Cash from Operations 44.39
Cash from Investing -31.92
Cash from Financing -4.57
Net change in Cash 0.68
Free Cash Flow 77.47
Particulars MAR 2020 (Values in Cr)
Net Income 8.27
Cash from Operations 30.53
Cash from Investing -20.84
Cash from Financing -0.66
Net change in Cash 2.83
Free Cash Flow 46.33
Particulars MAR 2024 (Values in Cr)
Net Income 51.53
Cash from Operations 73.86
Cash from Investing -74.60
Cash from Financing -1.90
Net change in Cash -17.44
Free Cash Flow 149.02
Particulars MAR 2023 (Values in Cr)
Net Income 63.83
Cash from Operations 98.74
Cash from Investing -56.92
Cash from Financing -10.66
Net change in Cash 18.92
Free Cash Flow 146.52
Particulars MAR 2022 (Values in Cr)
Net Income 55.34
Cash from Operations 75.24
Cash from Investing -37.88
Cash from Financing -16.14
Net change in Cash 4.64
Free Cash Flow 104.96
Particulars MAR 2021 (Values in Cr)
Net Income 28.39
Cash from Operations 44.17
Cash from Investing -31.87
Cash from Financing -4.57
Net change in Cash 0.52
Free Cash Flow 76.83
Particulars MAR 2020 (Values in Cr)
Net Income 8.34
Cash from Operations 30.42
Cash from Investing -20.09
Cash from Financing -1.45
Net change in Cash 2.81
Free Cash Flow 44.64
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6962.05 76.41 13.35 100103.60 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 75.38 183.85 4.73 141.28 51.01 / 98.70
SHREE PACETRONIX LTD. 70.00 14.58 1.87 25.20 61.11 / 268.50
TRANSGENE BIOTEK LTD. 3.68 0.00 2.57 27.88 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6962.05 83.30 12.22 100103.60 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 32.25 0.00 -17.27 24.09 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5560.50 29.47 6.24 6083.19 3750.00 / 6400.00

VIMTA LABS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
998.90 -3.72 redarrow
red-green-graph indicator
9 Bearish
7 Bullish
  • 5 Days 1030.90
  • 26 Days 1007.00
  • 10 Days 1024.60
  • 50 Days 987.70
  • 12 Days 1021.10
  • 100 Days 931.40
  • 20 Days 1011.70
  • 200 Days 822.90
1047.40 PIVOT

First Support

1006.50

First Resistance

1078.50

Second Support

975.40

Second Resistance

1119.40

Third Support

934.50

Third Resistance

1150.50

RSI

49.41

ADX

12.72

MACD

14.12

Williams % R

-50.62

Commodity Channel Index (CCI)

23.96

Date

2025-04-30

Week

95236.00

Same Day

50435.00

Month

62543.00

1 Year

1.16

3 Year

0.93

Over 1 Month

3.48%

down

Over 1 Year

86.44%

down

Over 3 Months

19.96%

down

Over 3 Years

39.67%

down

Over 6 Months

80.35%

down

Over 5 Years

65.72%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

VIMTA LABS LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
58.2%
Promoter Holdings
36.7%
FII
3.66%
DII
1.43%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Eurofins Analytical Services India Pvt Ltd 4403668.0 (19.81%) Public Shareholding
Sivalinga Prasad Vasireddi 2598525.0 (11.69%) Shareholding of Promoter and Promoter Group
Lcgc Chromatography Solutions Private Limited 2083175.0 (9.37%) Public Shareholding
Vangal Harriman 1772818.0 (7.97%) Shareholding of Promoter and Promoter Group
Vasireddi Veerabhadra Prasad 1463515.0 (6.58%) Shareholding of Promoter and Promoter Group
Praveena Vasireddi 1102535.0 (4.96%) Shareholding of Promoter and Promoter Group
Andhra Pradesh Industrial Development Corporation Limited 590000.0 (2.65%) Shareholding of Promoter and Promoter Group
Barca Global Master Fund Lp 506622.0 (2.28%) Public Shareholding
Harita Vasireddi 167964.0 (0.76%) Shareholding of Promoter and Promoter Group
Sireesh Chandra Vungal 113055.0 (0.51%) Shareholding of Promoter and Promoter Group
Swarna Latha Vasireddi 101535.0 (0.46%) Shareholding of Promoter and Promoter Group
Sudheshna Vungal 100879.0 (0.45%) Shareholding of Promoter and Promoter Group
Vungal Rajeswari 80725.0 (0.36%) Shareholding of Promoter and Promoter Group
Sujani Vasireddi 66325.0 (0.3%) Shareholding of Promoter and Promoter Group
Rajya Lakshmi Vasireddi 2300.0 (0.01%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

VIMTA LABS LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
21 Jun 2023 2.0 Final 22 Jun 2023 Equity shares
16 Jun 2022 2.0 Final 18 Jun 2022 Equity shares
25 Jun 2021 2.0 Final 28 Jun 2021 Equity shares
18 Jul 2019 2.0 Final 22 Jul 2019 Equity shares
14 Aug 2018 2.0 Final 20 Aug 2018 Equity shares
25 Aug 2016 1.0 Final 29 Aug 2016 Equity shares
06 Aug 2015 1.0 Final 10 Aug 2015 Equity shares
27 Jun 2014 2.0 Final 01 Jul 2014 Equity shares
23 May 2013 0.6 Final 27 May 2013 Equity shares
15 Sep 2011 0.4 Final 19 Sep 2011 Equity shares
23 Sep 2010 0.8 Final 27 Sep 2010 Equity shares
10 Sep 2009 0.8 Final 14 Sep 2009 Equity shares
28 Aug 2008 0.8 Final 01 Sep 2008 Equity shares
02 Aug 2007 0.8 Final 06 Aug 2007 Equity shares
01 Jun 2006 0.0 Final 01 Jan 0001 Equity shares
19 May 2005 0.0 Final 23 May 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
24 Feb 2006 10.0 2.0 03 Mar 2006
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
11 Jul 2024 2.0 Final 12 Jul 2024 Equity shares
21 Jun 2023 2.0 Final 22 Jun 2023 Equity shares
16 Jun 2022 2.0 Final 18 Jun 2022 Equity shares
25 Jun 2021 2.0 Final 28 Jun 2021 Equity shares
18 Jul 2019 2.0 Final 22 Jul 2019 Equity shares
14 Aug 2018 2.0 Final 20 Aug 2018 Equity shares
25 Aug 2016 1.0 Final 29 Aug 2016 Equity shares
06 Aug 2015 1.0 Final 10 Aug 2015 Equity shares
27 Jun 2014 2.0 Final 01 Jul 2014 Equity shares
23 May 2013 0.6 Final 27 May 2013 Equity shares
15 Sep 2011 0.4 Final 19 Sep 2011 Equity shares
23 Sep 2010 0.8 Final 27 Sep 2010 Equity shares
10 Sep 2009 0.8 Final 14 Sep 2009 Equity shares
28 Aug 2008 0.8 Final 01 Sep 2008 Equity shares
02 Aug 2007 0.8 Final 06 Aug 2007 Equity shares
01 Jun 2006 0.0 Final 01 Jan 0001 Equity shares
19 May 2005 0.0 Final 23 May 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
24 Feb 2006 10.0 2.0 03 Mar 2006

VIMTA LABS LIMITED Share Price

Vimta Labs Ltd., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas of preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.

In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.

During 2002, the company began to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.

During the year 2006-07, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006.

During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company.

In 2023-24, Emtac Laboratories Private Limited got amalgamated with the Company effective 01.04.2024.

Parent organization Indian Private
NSE symbol VIMTALABS
Founded 1990
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Vimta Labs Ltd?

Answer Field

The share price of Vimta Labs Ltd for NSE is ₹ 998.9 and for BSE is ₹ 1001.75.

What is the Market Cap of Vimta Labs Ltd?

Answer Field

The market cap of Vimta Labs Ltd for NSE is ₹ 22,14.62 Cr. and for BSE is ₹ 22,20.93 Cr. as of now.

What is the 52 Week High and Low of Vimta Labs Ltd?

Answer Field

The 52 Week High and Low of Vimta Labs Ltd for NSE is ₹ 1178.00 and ₹ 420.00 and for BSE is ₹ 1183.00 and ₹ 420.00.

How to Buy Vimta Labs Ltd share?

Answer Field

You can trade in Vimta Labs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Vimta Labs Ltd?

Answer Field

The 1 year returns on the stock has been 86.44%.

What is the Current Share Price of Vimta Labs Ltd?

Answer Field

Vimta Labs Ltd share price is for NSE ₹ 998.9 & for BSE ₹ 1001.75 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Vimta Labs Ltd Share?

Answer Field

The market cap of Vimta Labs Ltd for NSE ₹ 22,14.62 & for BSE ₹ 22,20.93 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Vimta Labs Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Vimta Labs Ltd share is 33.03.

What is the PB ratio of Vimta Labs Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Vimta Labs Ltd share is 170.38.

How to Buy Vimta Labs Ltd Share?

Answer Field

You can trade in Vimta Labs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vimta Labs Ltd Share on Bajaj Broking App?

Answer Field

To buy Vimta Labs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vimta Labs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|